Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Amyris (AMRS) stock

Learn how to easily invest in Amyris stock.

Amyris, Inc
NASDAQ: AMRS - USD
SPECIALTY CHEMICALS
$14.89
+$0.35 (+2.37%)

Amyris, Inc is a specialty chemicals business based in the US. Amyris shares (AMRS) are listed on the NASDAQ and all prices are listed in US Dollars. Amyris employs 595 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Amyris

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMRS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Amyris stock price (NASDAQ: AMRS)

Use our graph to track the performance of AMRS stocks over time.

Amyris shares at a glance

Information last updated 2021-07-23.
Latest market close$14.23
52-week range$1.88 - $23.42
50-day moving average $15.57
200-day moving average $14.75
Wall St. target price$24.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.39

Buy Amyris shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Amyris stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amyris price performance over time

Historical closes compared with the close of $14.23 from 2021-05-28

1 week (2021-07-17) N/A
1 month (2021-06-28) -14.94%
3 months (2021-04-28) -7.36%
6 months (2021-01-24) N/A
1 year (2020-07-24) N/A
2 years (2019-07-24) N/A
3 years (2018-07-24) N/A
5 years (2016-07-24) N/A

Is Amyris under- or over-valued?

Valuing Amyris stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amyris's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amyris's EBITDA

Amyris's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $11.1 million.

The EBITDA is a measure of a Amyris's overall financial performance and is widely used to measure a its profitability.

Amyris financials

Revenue TTM $320.9 million
Operating margin TTM 0.41%
Gross profit TTM $14.8 million
Return on assets TTM 0.34%
Return on equity TTM 0%
Profit margin -166.56%
Book value $-1.79
Market capitalisation $4.7 billion

TTM: trailing 12 months

Shorting Amyris shares

There are currently 21.7 million Amyris shares held short by investors – that's known as Amyris's "short interest". This figure is 17.7% up from 18.5 million last month.

There are a few different ways that this level of interest in shorting Amyris shares can be evaluated.

Amyris's "short interest ratio" (SIR)

Amyris's "short interest ratio" (SIR) is the quantity of Amyris shares currently shorted divided by the average quantity of Amyris shares traded daily (recently around 3.3 million). Amyris's SIR currently stands at 6.6. In other words for every 100,000 Amyris shares traded daily on the market, roughly 6600 shares are currently held short.

However Amyris's short interest can also be evaluated against the total number of Amyris shares, or, against the total number of tradable Amyris shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amyris's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Amyris shares in existence, roughly 70 shares are currently held short) or 0.124% of the tradable shares (for every 100,000 tradable Amyris shares, roughly 124 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Amyris.

Find out more about how you can short Amyris stock.

Amyris share dividends

We're not expecting Amyris to pay a dividend over the next 12 months.

Have Amyris's shares ever split?

Amyris's shares were split on a 1:15 basis on 5 June 2017. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amyris shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Amyris shares which in turn could have impacted Amyris's share price.

Amyris share price volatility

Over the last 12 months, Amyris's shares have ranged in value from as little as $1.88 up to $23.42. A popular way to gauge a stock's volatility is its "beta".

AMRS.US volatility(beta: 1.1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amyris's is 1.0968. This would suggest that Amyris's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Amyris overview

Amyris, Inc. , a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc.

Frequently asked questions

What percentage of Amyris is owned by insiders or institutions?
Currently 38.499% of Amyris shares are held by insiders and 38.538% by institutions.
How many people work for Amyris?
Latest data suggests 595 work at Amyris.
When does the fiscal year end for Amyris?
Amyris's fiscal year ends in December.
Where is Amyris based?
Amyris's address is: 5885 Hollis Street, EmeryVille, CA, United States, 94608
What is Amyris's ISIN number?
Amyris's international securities identification number is: US03236M2008
What is Amyris's CUSIP number?
Amyris's Committee on Uniform Securities Identification Procedures number is: 03236M101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site